Michael Trauner Selected Research

Michael Trauner Research Topics

Disease

153	Fibrosis (Cirrhosis) 03/2024 - 12/2005
123	Liver Diseases (Liver Disease) 04/2024 - 05/2002
86	Cholestasis 11/2023 - 01/2002
75	Inflammation (Inflammations) 03/2024 - 02/2006
56	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 11/2004
56	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2010
51	Portal Hypertension 03/2024 - 07/2011
46	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 04/2005
38	Sclerosing Cholangitis 11/2023 - 05/2003
32	Neoplasms (Cancer) 04/2024 - 04/2005
29	Fatty Liver 03/2024 - 02/2009
27	Infections 03/2024 - 05/2004
24	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 04/2003
22	End Stage Liver Disease 08/2023 - 11/2009
19	Hemorrhage 02/2024 - 11/2013
16	Disease Progression 05/2023 - 11/2010
16	Insulin Resistance 01/2023 - 01/2010
15	Ascites 02/2024 - 01/2014
12	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2012
11	COVID-19 01/2023 - 01/2020
10	Hepatitis C 03/2024 - 03/2015
9	Acute-On-Chronic Liver Failure 01/2024 - 03/2007
9	Critical Illness (Critically Ill) 01/2023 - 01/2012
9	Chronic Hepatitis C 01/2018 - 04/2003
8	Cholangitis 03/2024 - 02/2006
8	Varicose Veins (Varicose Vein) 03/2024 - 11/2013
8	Carcinogenesis 01/2016 - 01/2007
7	Hepatic Encephalopathy 02/2024 - 01/2018
7	Hepatitis 01/2024 - 08/2005
7	Alcoholic Fatty Liver 11/2023 - 11/2004
7	Liver Failure 12/2022 - 10/2003
6	Adenoma (Adenomas) 04/2024 - 09/2011
6	Body Weight (Weight, Body) 03/2024 - 04/2003
6	Necrosis 11/2023 - 03/2005
6	Pruritus (Itching) 01/2023 - 04/2005
6	Obesity 11/2022 - 08/2015
6	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2007
6	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 10/2003
6	Sepsis (Septicemia) 05/2021 - 10/2006
6	Cystic Fibrosis (Mucoviscidosis) 03/2020 - 01/2008
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 09/2011

Drug/Important Bio-Agent (IBA)

101	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 01/2002
32	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2024 - 05/2002
31	LipidsIBA 01/2023 - 01/2007
30	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2005
30	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2023 - 05/2004
25	Proteins (Proteins, Gene)FDA Link 09/2023 - 04/2005
23	BilirubinIBA 02/2024 - 04/2005
19	CytokinesIBA 02/2024 - 03/2005
19	EnzymesIBA 09/2023 - 04/2005
19	LigandsIBA 08/2023 - 05/2004
18	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024 - 07/2011
17	Antiviral Agents (Antivirals)IBA 03/2024 - 07/2011
17	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2010
15	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2012
14	von Willebrand FactorIBA 03/2024 - 10/2012
14	InterferonsIBA 04/2022 - 07/2011
13	Alkaline PhosphataseIBA 02/2024 - 08/2008
13	C-Reactive ProteinIBA 01/2024 - 06/2013
12	AcidsIBA 11/2023 - 06/2009
11	CholesterolIBA 11/2023 - 05/2002
11	Hydroxyproline (4 Hydroxyproline)IBA 11/2023 - 08/2008
11	AlbuminsIBA 08/2023 - 10/2016
10	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2011
10	gadolinium ethoxybenzyl DTPA FDA Link 12/2023 - 06/2014
10	Interleukin-6 (Interleukin 6)IBA 11/2023 - 04/2013
10	Messenger RNA (mRNA)IBA 11/2023 - 06/2006
10	Immunoglobulin G (IgG)IBA 05/2023 - 03/2012
10	Phospholipases (Phospholipase)IBA 01/2022 - 01/2012
9	Alanine Transaminase (SGPT)IBA 12/2022 - 04/2015
9	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020 - 01/2004
8	AntigensIBA 01/2024 - 10/2012
8	24-norursodeoxycholic acidIBA 11/2023 - 02/2006
8	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 06/2012
8	obeticholic acidIBA 12/2022 - 10/2011
8	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018 - 01/2002
7	CollagenIBA 03/2024 - 02/2015
7	Transaminases (Aminotransferases)IBA 03/2024 - 09/2007
7	Therapeutic UsesIBA 03/2024 - 06/2009
7	SodiumIBA 10/2023 - 10/2007
7	LipopolysaccharidesIBA 08/2023 - 10/2009
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 07/2012
6	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 02/2024 - 07/2015
6	cilofexorIBA 11/2023 - 01/2019
6	Immunoglobulin M (IgM)IBA 05/2023 - 01/2016
6	TransferasesIBA 01/2023 - 02/2010
6	selonsertibIBA 01/2023 - 11/2019
6	AntibodiesIBA 01/2021 - 03/2009
6	Peptides (Polypeptides)IBA 01/2020 - 10/2007
6	CopperIBA 05/2019 - 11/2004
6	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 07/2011
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2017 - 09/2003
6	Adenosine Triphosphate (ATP)IBA 10/2017 - 09/2003

Therapy/Procedure

63	Therapeutics 02/2024 - 04/2003
40	Liver Transplantation 10/2023 - 10/2003
19	Ligation 11/2023 - 06/2006
10	Transjugular Intrahepatic Portasystemic Shunt 12/2022 - 09/2017
8	Immunotherapy 02/2024 - 09/2016
7	Drug Therapy (Chemotherapy) 01/2021 - 04/2005
6	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022 - 12/2017